NO165945C - Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra). - Google Patents

Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra).

Info

Publication number
NO165945C
NO165945C NO851386A NO851386A NO165945C NO 165945 C NO165945 C NO 165945C NO 851386 A NO851386 A NO 851386A NO 851386 A NO851386 A NO 851386A NO 165945 C NO165945 C NO 165945C
Authority
NO
Norway
Prior art keywords
ggf
gra
monoclonal
preparation
glycosidic
Prior art date
Application number
NO851386A
Other languages
English (en)
Norwegian (no)
Other versions
NO851386L (no
NO165945B (no
Inventor
Masakazu Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO851386L publication Critical patent/NO851386L/no
Publication of NO165945B publication Critical patent/NO165945B/no
Publication of NO165945C publication Critical patent/NO165945C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A61K39/001192—Glycoprotein 100 [Gp100]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
NO851386A 1984-04-06 1985-04-03 Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra). NO165945C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59068668A JPS60214737A (ja) 1984-04-06 1984-04-06 糖鎖関連抗原の製造法

Publications (3)

Publication Number Publication Date
NO851386L NO851386L (no) 1985-10-07
NO165945B NO165945B (no) 1991-01-28
NO165945C true NO165945C (no) 1991-05-08

Family

ID=13380318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851386A NO165945C (no) 1984-04-06 1985-04-03 Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra).

Country Status (13)

Country Link
US (1) US4849510A (ko)
EP (1) EP0157427A3 (ko)
JP (1) JPS60214737A (ko)
KR (1) KR870001375B1 (ko)
AU (1) AU593210B2 (ko)
CA (2) CA1243607A (ko)
DK (1) DK147885A (ko)
ES (2) ES8608886A1 (ko)
FI (1) FI851373L (ko)
NO (1) NO165945C (ko)
PH (1) PH21133A (ko)
PT (1) PT80233B (ko)
ZA (1) ZA852491B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3787403D1 (de) * 1986-05-09 1993-10-21 Pulverer Gerhard Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore.
JPS62273919A (ja) * 1986-05-21 1987-11-28 Takahiro Ochi 抗リウマチ剤
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
JPH03263401A (ja) * 1990-03-13 1991-11-22 Nippon Koutai Kenkyusho:Kk 新規糖鎖
MD838G2 (ro) * 1992-07-21 1998-09-30 Alexandr Nicolaenco Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
DE19806185C2 (de) * 1998-02-02 1999-11-18 Biogenes Gmbh Immunoassay und Testkit zur Bestimmung von fucosyliertem Protein in einer biologischen Probe
TWI337868B (en) * 2004-05-21 2011-03-01 Tzu Chi Buddhist General Hospital Method for extracting extract from chaenomeles lagenaria and the applications thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US4211766A (en) * 1972-07-10 1980-07-08 Ab Bonnierforetagen Cancer associated polypeptide antigen compositions
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
CH645728A5 (fr) * 1979-01-30 1984-10-15 Otsuka Pharma Co Ltd Procede de determination de la teneur en substances contenant des liaisons glucosidiques associees aux tumeurs, application de ce procede et necessaire pour sa mise en oeuvre.
US4334017A (en) * 1979-04-16 1982-06-08 Massachusetts Institute Of Technology Method for detecting cancer in mammalian tissue
NO161601C (no) * 1981-10-01 1989-09-06 Otsuka Pharma Co Ltd Fremgangsmaate for fremstilling av et glykorelatert antigen
GB2106935B (en) * 1981-10-01 1985-01-30 Otsuka Pharma Co Ltd Cancer cell-combatting lymphocytes process for the production thereof and anticancer agents containing said lymphocytes
CH653442A5 (en) * 1982-01-29 1985-12-31 Otsuka Pharma Co Ltd Process for the determination of tumour-associated glucoside derivatives
AU556941B2 (en) * 1982-10-08 1986-11-27 Otsuka Pharmaceutical Co., Ltd. Glycosidic linkage related antigen
ES8600692A1 (es) * 1982-10-08 1985-11-01 Otsuka Pharma Co Ltd Procedimiento de producir antigenos y sus intermedios

Also Published As

Publication number Publication date
ZA852491B (en) 1985-11-27
EP0157427A3 (en) 1987-08-12
ES551356A0 (es) 1987-07-01
ES542835A0 (es) 1986-09-16
JPS60214737A (ja) 1985-10-28
ES8608886A1 (es) 1986-09-16
PH21133A (en) 1987-07-27
PT80233B (en) 1987-03-16
AU593210B2 (en) 1990-02-08
FI851373L (fi) 1985-10-07
FI851373A0 (fi) 1985-04-04
NO851386L (no) 1985-10-07
CA1243607A (en) 1988-10-25
KR850007431A (ko) 1985-12-04
US4849510A (en) 1989-07-18
DK147885A (da) 1985-10-07
DK147885D0 (da) 1985-04-01
CA1240214A (en) 1988-08-09
PT80233A (en) 1985-05-01
ES8706447A1 (es) 1987-07-01
EP0157427A2 (en) 1985-10-09
NO165945B (no) 1991-01-28
KR870001375B1 (ko) 1987-07-24
AU4081085A (en) 1985-10-10

Similar Documents

Publication Publication Date Title
BR8507031A (pt) Anticorpo monoclonal para um antigeno associado com tumor de carcinoma
DK666389D0 (da) Monoklonalt antistof
ES516797A0 (es) Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
DE68914244D1 (de) Monoklonaler Antikörper.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
DK65185A (da) Fremgangsmaade til fremstilling af antistof
DE3885355D1 (de) Monoklonale Antikörper.
DK63187A (da) Krydsbeskyttende monoklonale antistofpraeparater
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
ES541102A0 (es) Procedimiento para la valoracion inmunologica de una subs- tancia, especialmente un antigeno un hapteno o un anticuerpo
DE3687487D1 (de) Monoklonaler antikoerper, spezifisch fuer ein pigmentationassoziiertes antigen.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DK188185A (da) Monoklonalt antistof
NO165945C (no) Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra).
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
NO894444L (no) Anti-fucosylceramid monoklonalt antistoff.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK717888D0 (da) Monoklonale antistoffer
DK37785D0 (da) Monoclonalt antistof
DK144485A (da) Monoklonale antistoffer
MX3601A (es) Anticuerpos monoclonales contra glicoproteinas asociadas a tumores, procedimiento para su preparacion y empleo
IT8548762A0 (it) Linfochina, suo anticorpo specifico monoclonale e relativo procedimentodi produzione
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO873488L (no) Monoklonale antistoffer.